GoodRx Corp - רווח למניה ב-12 החודשים האחרונים GDRX

GoodRx Holdings, Inc. (GDRX) generates revenue from pharmacy and PBM commissions by leveraging high trust among consumers seeking affordable medications. The relative YoY EPS growth over the last 12 months illustrates profit dynamics, where -49.70 represents the current metric value. The business possesses benchmark IT scalability, generating ultra-high-margin revenue by routing traffic without incurring logistics or drug storage costs.
GoodRx Holdings, Inc. - פילוחים אנליטיים ומדדי מפתח (GDRX)

By scaling commission income through drug price optimization, GoodRx Holdings, Inc. (GDRX) remains exposed to PBM contract terms and pharmacy chain dynamics. This metric measures the percentage change in net income per share on a rolling year basis, allowing for an assessment of business capitalization rates and the determination of a fair control premium by analyzing the annual volatility of TTM net income per share.